... If they can maintain the dividend through this rough patch then I think they are a screaming buy at these levels. If I discover otherwise, I will exit.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025